Our hope is that studies that distinguish between the molecular mechanisms of IL-6 contribution to LQTS and AF may reveal important mechanistic insights that will inform targeted therapeutic interventions that will be beneficial to all patients and help improve quality of life. Here, IL6 is linked to familial long QT syndrome.